summit trial tirzepatide Effects of on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the AHA 24 Late-Breaking Discussion: SUMMIT:

doi: 10.3322/caac.21660 2 VitekLHubacekJAPajakADoryskaAKozelaMEremiasovaLet al

In contrast, control rats exhibited goal-directed navigation characterized by direct platform approaches (Fig

Orforglipron is it's oral treatment drug for type 2 diabetes and obesity

The constant mechanical loading from daily walking and standing makes it difficult for healing tissue to rest and remodel

In February 2021, the researchers published findings from the STEP 1 trial in The New England Journal of Medicine showing that patients who injected Ozempic (semaglutide) lost close to 15% of their body weight , on average, compared with 2.4% among patients receiving the placebo